Drug-induced experimental Parkinsonism.
D000818:Animals; D001285:Atropine / Q000627:therapeutic use; D001590:Benztropine / Q000494:pharmacology; D002090:Butyrophenones / Q000494:pharmacology; D002415:Cats; D002746:Chlorpromazine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004576:Electromyography; D009046:Motor Neurons / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D010640:Phenothiazines / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D013742:Tetanus / Q000139:chemically induced; D013997:Time Factors; D014203:Tremorine / Q000494:pharmacology; D014268:Trifluoperazine / Q000494:pharmacology
D002090:Butyrophenones; D010640:Phenothiazines; D001590:Benztropine; D014268:Trifluoperazine; D001285:Atropine; D012110:Reserpine; D002746:Chlorpromazine; D014203:Tremorine